Search

Search Constraints

You searched for: Author/Creator Peters, S

Search Results

2. 1385PDA randomised phase III trial evaluating the addition of denosumab to standard first-line treatment in advanced NSCLC: The ETOP and EORTC SPLENDOUR trial. (23rd October 2018)

3. 1399PImpact of lorlatinib on patient-reported outcomes (PROs) in patients (Pts) with advanced ALK+ or ROS1+ non-small cell lung cancer (NSCLC). (23rd October 2018)

4. 205 Biological mechanisms that underlie shiftwork as a risk factor for breast cancer. (11th October 2013)

7. 474O Efficacy and safety of first-line durvalumab (D) ± tremelimumab (T) vs chemotherapy (CT) in Asian patients with metastatic NSCLC: Results from MYSTIC. (24th November 2019)